Institutional investors purchased a net $7.2 million shares of IMMU during the quarter ended December 2015, and now own 50.18% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OPPENHEIMER & CO., INC. (WEALTH ... Sold 3.8 Thousand shares of Immunomedics Inc
BNP PARIBAS ARBITRAGE SNC Sold 9.7 Thousand shares of Immunomedics Inc
CREATIVE PLANNING, INC. Sold 14.0 Thousand shares of Immunomedics Inc